A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Celontin Indications, Dosage, Storage, Stability - Methsuximide
Celontin Indications, Dosage, Storage, Stability - Methsuximide
INDICATIONS
AND USES
Celontin is indicated for the control of absence (petit mal) seizures that
are refractory to other drugs.
DOSAGE AND ADMINISTRATION
Optimum dosage of Celontin must be determined by trial. A suggested dosage
schedule is 300 mg per day for the first week. If required, dosage may be increased
thereafter at weekly intervals by 300 mg per day for the three weeks following
to a daily dosage of 1.2 g. Because therapeutic effect and tolerance vary among
patients, therapy with Celontin must be individualized according to the response
of each patient. Optimal dosage is that amount of Celontin which is barely sufficient
to control seizures so that side effects may be kept to a minimum. The smaller
capsule (150 mg) facilitates administration to small children.
Celontin may be administered in combination with other anticonvulsants when
other forms of epilepsy coexist with absence (petit mal).
HOW SUPPLIED
N 0071-0525-24 (P-D 525) Celontin capsules, #1 capsule each containing 300
mg methsuximide; bottles of 100.
N 0071-0537-24 (P-D 537) Celontin capsules, Half Strength, #3 capsule each
containing 150 mg methsuximide, bottles of 100.
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled
Room Temperature].
Protect from light and moisture.
Protect from excessive heat 40°C (104°F).
Rx only
©1997-'00, Warner-Lambert Co.
PARKE-DAVIS
Div. of Warner-Lambert Co
Morris Plains, NJ 07950 USA
MADE IN FRANCE
top
